Sheffield Hallam University, in partnership with the BBSRC Yorkshire Bioscience Doctoral Training Partnership (YBDTP), is offering a fully funded PhD studentship focused on cancer biology, systems biology, and advanced bioinformatics. The project, supervised by Dr Lewis Quayle (Senior Lecturer in Data Science and Analytics), Dr Nik Georgopoulos (Sheffield Hallam University), and Professor Penelope Ottewell (University of Sheffield), aims to unravel the molecular mechanisms underlying tumour cell dormancy in breast cancer and the drivers of metastatic relapse. This unique, multidisciplinary project will leverage advanced transcriptomic analytics, systems biology, and spatial omics to decode the regulatory networks that underpin mitotic quiescence in disseminated tumour cells. The successful applicant will interrogate unique RNA-seq datasets from novel dormancy models and validate key mechanisms using 10x Genomics Xenium spatial transcriptomics. The research will provide hands-on experience in high-performance computing, bioinformatics, network biology, and translational research at the interface of computational and experimental biology. The programme is open to applicants worldwide and is based in Sheffield, UK. The position is fully funded through the BBSRC Yorkshire Bioscience DTP, covering tuition fees and providing a stipend. The project is ideal for candidates with a passion for cancer biology, computational biology, or bioinformatics, and offers the opportunity to build cutting-edge skills in a collaborative, cross-disciplinary environment. The ultimate goal is to develop a mechanistic framework for tumour cell persistence and reactivation, providing insights that could help prevent metastatic relapse in breast cancer. For more information and to apply, visit the application link provided. Informal enquiries can be directed to Dr Lewis Quayle at l.quayle@shu.ac.uk.

A new PhD studentship is available through a collaboration between Newcastle University, The University of Sheffield, and industry partners. This opportunity is ideal for UK students interested in developing advanced, precision therapies targeting prostate cancer. The project will likely involve interdisciplinary research at the intersection of cancer biology and therapeutic development, with access to expertise and resources from both academic institutions and industry collaborators. The studentship is supervised by Professor Penelope Ottewell, a leading expert in cancer biology at the University of Sheffield. While specific funding details and application requirements are not provided in the announcement, interested candidates are encouraged to follow the provided link for further information and to apply. This position offers a unique chance to contribute to cutting-edge research in cancer therapy within a supportive and innovative environment.

<p>This fully funded PhD opportunity at Sheffield Hallam University, offered through the BBSRC Yorkshire Bioscience Doctoral Training Partnership (YBDTP), focuses on understanding tumour cell dormancy in breast cancer using systems biology and advanced multi-omics approaches. The project is supervised by Dr Lewis Quayle (Sheffield Hallam University), in collaboration with Dr Nik Georgopoulos (Sheffield Hallam University) and Professor Penelope Ottewell (University of Sheffield). The research aims to unravel the molecular mechanisms underlying mitotic quiescence and metastatic relapse by interrogating unique RNA-seq datasets from novel dormancy models and validating findings with 10x Genomics Xenium spatial transcriptomics.</p><p>The successful candidate will gain hands-on experience in high-performance computing, bioinformatics, network biology, and spatial omics, working at the interface of computational biology, molecular oncology, and translational research. The project offers a unique multidisciplinary environment, combining computational and experimental biology to address key questions in cancer persistence and reactivation. The ultimate goal is to develop a mechanistic framework that could inform strategies to prevent metastatic relapse in breast cancer patients.</p><p>The position is open to applicants worldwide and is based in Sheffield, UK. Funding is provided by the BBSRC and covers tuition fees and a stipend for living expenses. Applicants should have a strong background in biological sciences, computational biology, or bioinformatics, with experience in relevant techniques highly desirable. The application deadline is 7th January 2026. For more information and to apply, visit the provided links or contact Dr Lewis Quayle at l.quayle@shu.ac.uk.</p>